As on Wednesday, uniQure N.V (NASDAQ: QURE) got off with the flyer as it spiked 2.98% to $14.87, before settling in for the price of $14.44 at the close. Taking a more long-term approach, QURE posted a 52-week range of $4.45-$19.18.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
The Healthcare Sector giants’ yearly sales growth during the last 5-year period was -9.66%. Meanwhile, its Annual Earning per share during the time was -9.66%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 29.07%. This publicly-traded company’s shares outstanding now amounts to $54.70 million, simultaneously with a float of $49.64 million. The organization now has a market capitalization sitting at $814.11 million. At the time of writing, stock’s 50-day Moving Average stood at $14.51, while the 200-day Moving Average is $11.78.
uniQure N.V (QURE) Ownership Facts and Figures
Another important factor to analyze is how key investors are playing towards the stock of the Biotechnology industry. uniQure N.V’s current insider ownership accounts for 9.33%, in contrast to 90.47% institutional ownership. According to the most recent insider trade that took place on Jun 27 ’25, this organization’s Chief Medical Officer sold 1,466 shares at the rate of 13.92, making the entire transaction reach 20,407 in total value, affecting insider ownership by 150,437. Preceding that transaction, on Jun 20 ’25, Company’s Director sold 2,112 for 14.45, making the whole transaction’s value amount to 30,518. This particular insider is now the holder of 37,694 in total.
uniQure N.V (QURE) Earnings and Revenue Records
uniQure N.V’s EPS increase for this current 12-month fiscal period is 29.07% and is forecasted to reach -3.03 in the upcoming year. Considering the longer run, market analysts have predicted that Company’s EPS will increase by 37.74% through the next 5 years, which can be compared against the -9.66% growth it accomplished over the previous five years trading on the market.
uniQure N.V (NASDAQ: QURE) Trading Performance Indicators
Let’s observe the current performance indicators for uniQure N.V (QURE). It’s Quick Ratio in the last reported quarter now stands at 11.99. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 40.30.
In the same vein, QURE’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -4.39, a figure that is expected to reach -0.89 in the next quarter, and analysts are predicting that it will be -3.03 at the market close of one year from today.
Technical Analysis of uniQure N.V (QURE)
Through scrutinizing the latest numbers posted by the [uniQure N.V, QURE], it can be observed that its last 5-days Average volume of 0.82 million was lower the volume of 1.43 million, it posted the year before. During the previous 9 days, stock’s Stochastic %D was recorded 73.99% While, its Average True Range was 57.76%.
Raw Stochastic average of uniQure N.V (QURE) in the period of the previous 100 days is set at 72.26%, which indicates a major fall in contrast to 73.91% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 0.72 that was lower than 1.07 volatility it exhibited in the past 100-days period.
